Engineers Gate Manager LP Vbi Vaccines Inc Transaction History

Engineers Gate Manager LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.38 - $22.5 $91 - $5,422	241 Added 1.85%	13,278 $5,000
Q3 2022 Nov 14, 2022	SELL	$0.73 - $23.4 $1,203 - $38,563	-1,648 Reduced 11.22%	13,037 $9,000
Q2 2022 Aug 15, 2022	SELL	$0.66 - $1.81 $811 - $2,224	-1,229 Reduced 7.72%	14,685 $12,000
Q1 2022 May 16, 2022	BUY	$1.27 - $2.47 $20,210 - $39,307	15,914 New	15,914 $26,000
Q3 2021 Nov 15, 2021	SELL	$2.8 - $3.72 $38,810 - $51,562	-13,861 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.61 - $4.17 $36,177 - $57,800	13,861 New	13,861 $46,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.